NeuroSense Therapeutics Ltd

NEW
NAS:NRSN (Israel)  
$ 0.76 -0.0010 (-0.13%) 07:09 PM EST
At Loss
Market Cap:
$ 27.40M
Enterprise V:
$ 27.40M
Volume:
199.44K
Avg Vol (2M):
152.90K
Trade In:
Volume:
199.44K
At Loss
Avg Vol (2M):
152.90K

NeuroSense Therapeutics Ltd (NRSN) Dividend

NeuroSense Therapeutics Ltd (NRSN) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -40.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: NRSN Dividend

Does NeuroSense Therapeutics Ltd (NRSN) pay a dividend?

NeuroSense Therapeutics Ltd (NRSN) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't NeuroSense Therapeutics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. NeuroSense Therapeutics Ltd has returned capital to shareholders via buybacks at a rate of -40.3% over the past 3 years.

What are dividend-paying alternatives to NeuroSense Therapeutics Ltd?

For dividend-paying alternatives in NeuroSense Therapeutics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.